Checkpoint Inhibitors as First-line Treatments for Lung Cancer: What You Need to Know

Checkpoint Inhibitors as First-line Treatments for Lung Cancer: What You Need to Know

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 6/29/2021

Max Credits: 1

View Activity

Advancing Science in Sickle Cell Disease: Implications for the Future of Care

Advancing Science in Sickle Cell Disease: Implications for the Future of Care

Sickle cell disease (SCD) is a heterogeneous disorder characterized by sev…

Expiration Date: 3/23/2021

Max Credits: 1.5

View Activity

Clinical Advances and Emerging Trends in Melanoma: A Symposium at the Society for Melanoma Research 2019 Congress

Clinical Advances and Emerging Trends in Melanoma: A Symposium at the Society for Melanoma Research 2019 Congress

In this educational activity, experts in the field review the patient, dis…

Expiration Date: 3/18/2021

Max Credits: 0.75

View Activity

Melanoma—BRAF-Mutated Disease, Checkpoint Inhibitors, Emerging Trends, and Challenging Cases

Melanoma—BRAF-Mutated Disease, Checkpoint Inhibitors, Emerging Trends, and Challenging Cases

In this educational activity, experts in the field review the patient, dis…

Expiration Date: 3/16/2021

Max Credits: 2.25

View Activity

Integrating New Options in Hepatocellular Carcinoma and Colorectal Cancer in the Community

Integrating New Options in Hepatocellular Carcinoma and Colorectal Cancer in the Community

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 2/18/2021

Max Credits: 1.25

View Activity

Chronic Lymphocytic Leukemia and Multiple Myeloma in the Community: Improving Outcomes with the Latest Clinical Advances

Chronic Lymphocytic Leukemia and Multiple Myeloma in the Community: Improving Outcomes with the Latest Clinical Advances

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 2/9/2021

Max Credits: 1.25

View Activity

Managing NSCLC and SCLC in the Community: What You Need to Know About the Latest Advances in Targeted Therapies and Immune Checkpoint Inhibitors

Managing NSCLC and SCLC in the Community: What You Need to Know About the Latest Advances in Targeted Therapies and Immune Checkpoint Inhibitors

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 2/26/2021

Max Credits: 1

View Activity

Updates in Newly Diagnosed PTCL

Updates in Newly Diagnosed PTCL

Peripheral T-cell lymphomas (PTCLs) are a highly heterogeneous and typical…

Expiration Date: 11/10/2020

Max Credits: 0.25

View Activity

Antibody-Drug Conjugates in PTCL

Antibody-Drug Conjugates in PTCL

Peripheral T-cell lymphomas (PTCLs) are a highly heterogeneous and typical…

Expiration Date: 11/10/2020

Max Credits: 0.25

View Activity

Updates in Diagnosis of PTCL and the Role of CD30

Updates in Diagnosis of PTCL and the Role of CD30

Peripheral T-cell lymphomas (PTCLs) are a highly heterogeneous and typical…

Expiration Date: 10/20/2020

Max Credits: 0.25

View Activity